Back

Summary of Edition of 20 April 2018

European Initiatives unite to address Integrated and Holistic care needs for Rare and Complex Conditions

Orphanet has released Spanish translations of its Emergency Guidelines

Early paediatric surgical care for birth defects

Early insight into the impact of the Cross-Border Healthcare Directive

Do new copyright reforms put open-science at risk?

Model-based cost effectiveness analysis: a useful tool to gauge cost-effectiveness of novel genomic diagnostic tests

Value-based Pricing for orphan drugs

FaceMatch: a new tool for facial recognition to help diagnosing intellectual disabled patients

The era of cloud computing for genomic resources

Genomic screening: What is the potential for paediatricians?

Mitochondrial disease: A diagnostic burden for patients

FDA granted new indication of Blincyto in the treatment of acute lymphoblastic leukemia with risk of relapse

Multi-criteria decision analysis: Useful HTA tool for orphan drugs

Treatments' effect Comparison of FDA approved therapeutics' treatment effects

Adaptive designs: what are the benefits when used in clinical trials?

Rare genetic disease: Brazil subject to inclusion and exclusion in the globalisation of genomics

ERN-EYE: 3rd Annual General Meeting

Credits

OrphaNews, The Newsletter of the Rare Diseases Community.
OrphaNews is supported by the European Commission's DG SANTE (RD-ACTION Joint Action N° 677024) and the French Muscular Dystrophy Association (AFM)
Editor-in-chief: Kate Bushby, Ana Rath
Editor:  Déborah Deprez, Divya Unni
Editor for Scientific Content: Sophie Höhn
Contact Us
Editorial Board: Valentina Bottarelli, Teresinha Evangelista, Victoria Hedley, Yann Le Cam, Charlotte Rodwell, Domenica Taruscio, Ariane Weinmann

Advisory Editorial Board: Ségolène Aymé, Anna Bucsics, Paul Boom, Bruno Dallapiccola, Jordi Llinares-Garcia, Alastair Kent, Milan Macek, Till Voigtländer

INTERNATIONAL CORRESPONDENTS
Orphanet Partner Country Representatives: Romi Armando (Argentina), Kristine Hovhannesyan (Armenia), Hugh Dawkins (Australia), Till Voigtlander (Austria), Rumen Stefanov (Bulgaria), Micheil Innes (Canada), Ingeborg Barisic (Croatia), Violetta Anastasiadou (Cyprus), Milan Macek (Czech Republic), John Rosendahl Ostergaard (Denmark), Vallo Tillmann (Estonia), Sirpa Ala-Mello (Finland), Joerg Schmidtke (Germany), Eileen Treacy (Ireland), Annick Raas-Rothschild (Israel), Bruno Dallapiccola (Italy), Tomoko Kodama (Japan), Jana Lepiksone (Latvia), André Mégarbané (Lebanon), Vaidutis Kucinskas (Lithuania), Yolande Wagener (Luxembourg), Abdelaziz Sefiani (Morocco), Gert-Jan van Ommen (Netherlands), Stein Are Aksnes (Norway), Malgorzata Krajewska-Walasek (Poland), Paul Nogueira (Portugal), Cristina Rusu (Romania), Dragica Radojkovic (Serbia), Laszlo Kovacs (Slovakia), Luca Lovrecic (Slovenia), Francesc Palau (Spain), Désirée Gavhed (Sweden), Loredana D'Amato Sizonenko (Switzerland), Dorra H'mida (Tunisia), Ugur Ozbek (Turkey), Sarah Stevens (UK) 
Orphanet - All rights reserved


Disclaimer: This newsletter is part of the project / joint action .677024 / RD-ACTION. which has received funding from the European Union.s Health Programme (2014-2020).
The content of newsletter represents the views of the Editorial Board only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.

 

Photo credit : Serimedis (unless otherwise stated)